Anesthesia for a 10-year-old boy with Duchenne muscular dystrophy syndrome: A case report.
10.4097/kjae.2008.55.2.217
- Author:
Hyun Ho SHIN
1
;
Dong Ho PARK
;
Chung LEE
;
Sung Chang WOO
;
Young Joo KIM
;
Jung Ha JOO
;
Han Young KIM
Author Information
1. Department of Anesthesiology and Pain Medicine, Eulji University Hospital, College of Medicine, Eulji University, Daejeon, Korea. donghop6212@dreamwiz.com
- Publication Type:Case Report
- Keywords:
cardiac arrest;
DMD;
rhabdomyolysis;
TCI
- MeSH:
Anesthesia;
Anesthesia, General;
Anesthetics;
Atracurium;
Atrophy;
Child;
Halothane;
Heart Arrest;
Humans;
Hyperkalemia;
Infusions, Intravenous;
Malignant Hyperthermia;
Muscle Weakness;
Muscles;
Muscular Dystrophy, Duchenne;
Piperidines;
Propofol;
Resuscitation;
Rhabdomyolysis;
Strabismus
- From:Korean Journal of Anesthesiology
2008;55(2):217-220
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Duchenne muscular dystrophy (DMD) is an eventually fatal disorder that is characterized by rapidly progressive muscle weakness and atrophy of muscle tissue. The clinical manifestations of DMD vary depending on the stages of the disease. Succinylcholine-induced hyperkalemia and the administration of volatile anesthetic agents, - particularly halothane, - during acute rhabdomyolysis are more likely to result in cardiac arrest and unsuccessful resuscitation in DMD patients than in the general public. This is a case report of a 10-year-old boy who underwent elective strabismus revision under general anesthesia. Anesthesia was induced and maintained with intravenous propofol and remifentanil, which was started at the targeted effect concentration of 3.0micrometer/ml and 3.5 ng/ml respectively via target controlled infusion (TCI). No inhaled anesthetic was used. In addition, an initial dose 0.4 mg/kg of atracurium was injected intravenously over 15s. The results of this case report found intravenous infusion of propofol, remifentanil and atracurium to be safe because the malignant hyperthermia did not occur.
